Diphenylhydantoin as an antiarrhythmic drug.
D000284:Administration, Oral; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy* / Q000209:etiology; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D006328:Cardiac Catheterization / Q000009:adverse effects; D006348:Cardiac Surgical Procedures / Q000009:adverse effects; D003327:Coronary Disease / Q000188:drug therapy; D003864:Depression, Chemical; D004070:Digitalis; D004077:Digoxin / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D006331:Heart Diseases / Q000188:drug therapy; D006801:Humans; D007275:Injections, Intravenous; D010042:Ouabain; D010672:Phenytoin / Q000008:administration & dosage / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D010946:Plants, Medicinal; D010947:Plants, Toxic; D014693:Ventricular Fibrillation / Q000188:drug therapy
D010042:Ouabain; D010672:Phenytoin; D004077:Digoxin